相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ENGAGE and EMERGE: Truth and consequences?
Lewis H. Kuller et al.
ALZHEIMERS & DEMENTIA (2021)
Evaluation of Aducanumab for Alzheimer Disease Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility
G. Caleb Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
The Problem of Aducanumab for the Treatment of Alzheimer Disease
G. Caleb Alexander et al.
ANNALS OF INTERNAL MEDICINE (2021)
Aducanumab: What about the Patient?
Ronald C. Petersen
ANNALS OF NEUROLOGY (2021)
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois et al.
LANCET NEUROLOGY (2021)
Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab
Gil D. Rabinovici
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Revisiting FDA Approval of Aducanumab
G. Caleb Alexander et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Treatments for Alzheimer's disease emerge
Dennis J. Selkoe
SCIENCE (2021)
Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective
Billy Dunn et al.
JAMA INTERNAL MEDICINE (2021)
2021 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2021)
Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2021)
Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease A Randomized Clinical Trial
Robert Howard et al.
JAMA NEUROLOGY (2020)
Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration
Md Sahab Uddin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in anex vivosystem
Christian Tackenberg et al.
PLOS ONE (2020)
A narrative review of brain-derived neurotrophic factor (BDNF) on cognitive performance in Alzheimer's disease
Noor Azila Ismail et al.
GROWTH FACTORS (2020)
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Alzheimer's Disease, Inflammation, and the Role of Antioxidants
Benjamin Sinyor et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2020)
Current and Future Treatments in Alzheimer Disease: An Update
Konstantina G. Yiannopoulou et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2020)
MAPT mutations, tauopathy, and mechanisms of neurodegeneration
Kevin H. Strang et al.
LABORATORY INVESTIGATION (2019)
Ambient Air Pollution, Noise, and Late-Life Cognitive Decline and Dementia Risk
Kimberly C. Paul et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 40 (2019)
Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease
Michael F. Egan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms
Minna Oksanen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzman-Martinez et al.
FRONTIERS IN PHARMACOLOGY (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
Martin R. Farlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Implications of sleep disturbance and inflammation for Alzheimer's disease dementia
Michael R. Irwin et al.
LANCET NEUROLOGY (2019)
A critical appraisal of amyloid-βtargeting therapies for Alzheimer disease
Francesco Panza et al.
NATURE REVIEWS NEUROLOGY (2019)
Alzheimer's disease drug development pipeline: 2019
Jeffrey Cummings et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2019)
Differential contribution of microglia and monocytes in neurodegenerative diseases
Caroline Baufeld et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
Nicole Cortes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
Joseph W. Arndt et al.
SCIENTIFIC REPORTS (2018)
Microglia in neurodegeneration
Suzanne Hickman et al.
NATURE NEUROSCIENCE (2018)
Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology
Roger N. Rosenberg et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Shane A. Liddelow et al.
IMMUNITY (2017)
Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease
Eleni Andreadou et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
Kerstin Berer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid β (1-42) in mice
Michelle Lima Garcez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
Oligodendrocytes and Alzheimer's disease
Zhiyou Cai et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2016)
Tau in physiology and pathology
Yipeng Wang et al.
NATURE REVIEWS NEUROSCIENCE (2016)
Alzheimer's Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-β with Regard to Potential Treatment and Prevention
Herbert B. Allen
JOURNAL OF ALZHEIMERS DISEASE (2016)
Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review
Manivannan Yegambaram et al.
CURRENT ALZHEIMER RESEARCH (2015)
Neuroinflammation in Alzheimer's disease
Michael T. Heneka et al.
LANCET NEUROLOGY (2015)
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R. Scott Turner et al.
NEUROLOGY (2015)
The role of protein clearance mechanisms in organismal ageing and age-related diseases
David Vilchez et al.
NATURE COMMUNICATIONS (2014)
Interactions of metals and Apolipoprotein E in Alzheimer's disease
He Xu et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Antioxidant role of amyloid β protein in cell-free and biological systems: implication for the pathogenesis of Alzheimer disease
Maitrayee Sinha et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Alzheimer Mechanisms and Therapeutic Strategies
Yadong Huang et al.
CELL (2012)
Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
Bengt Winblad et al.
LANCET NEUROLOGY (2012)
The interplay between the intestinal microbiota and the brain
Stephen M. Collins et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
John M. Ringman et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
Neurotoxicity of Amyloid β-Protein: Synaptic and Network Dysfunction
Lennart Mucke et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Air Pollution, Oxidative Stress, and Alzheimer's Disease
Paula Valencia Moulton et al.
JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH (2012)
EHT0202 in Alzheimer's Disease: A 3-Month, Randomized, Placebo-Controlled, Double-Blind Study
B. Vellas et al.
CURRENT ALZHEIMER RESEARCH (2011)
Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria
Judith Miklossy
JOURNAL OF NEUROINFLAMMATION (2011)
The Second-Generation Active Aβ Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wiessner et al.
JOURNAL OF NEUROSCIENCE (2011)
Aβ oligomers inhibit synapse remodelling necessary for memory consolidation
Darragh B. Freir et al.
NEUROBIOLOGY OF AGING (2011)
Cognitive effects of cell-derived and synthetically derived Aβ oligomers
Miranda N. Reed et al.
NEUROBIOLOGY OF AGING (2011)
Alzheimer's disease as homeostatic responses to age-related myelin breakdown
George Bartzokis
NEUROBIOLOGY OF AGING (2011)
Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation
Tai-Chun Huang et al.
PLOS ONE (2011)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Cigarette Smoking is a Risk Factor for Alzheimer's Disease: An Analysis Controlling for Tobacco Industry Affiliation
Janine K. Cataldo et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Valerie Vingtdeux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Can Alzheimer disease be prevented by amyloid-β immunotherapy?
Cynthia A. Lemere et al.
NATURE REVIEWS NEUROLOGY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Neuroinflammation - An Early Event in Both the History and Pathogenesis of Alzheimer's Disease
Piet Eikelenboom et al.
NEURODEGENERATIVE DISEASES (2010)
Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease LEADe
H. H. Feldman et al.
NEUROLOGY (2010)
Analysis of three plasmid systems for use in DNA Aβ42 immunization as therapy for Alzheimer's disease
Bao-Xi Qu et al.
VACCINE (2010)
The Role of Neuroimmunomodulation in Alzheimer's Disease
Ricardo B. Maccioni et al.
NEUROIMMUNOMODULATION: FROM FUNDAMENTAL BIOLOGY TO THERAPY (2009)
Involvement of protein trafficking in deprenyl-induced α-secretase activity regulation in PC12 cells
Hong-Qi Yang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
DNA β-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
Doris Lambracht-Washington et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
β-Amyloid Monomers Are Neuroprotective
Maria Laura Giuffrida et al.
JOURNAL OF NEUROSCIENCE (2009)
The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research
Sang-Ho Choi et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
Roy O Weller et al.
Alzheimers Research & Therapy (2009)
A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease
Patrizio Pasqualetti et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Inflammation and Alzheimer's disease: Possible role of periodontal diseases
Angela R. Kamer et al.
ALZHEIMERS & DEMENTIA (2008)
The aging brain
Bruce A. Yankner et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT)
ARCHIVES OF NEUROLOGY (2008)
New insights into brain BDNF function in normal aging and Alzheimer disease
Lucia Tapia-Arancibia et al.
BRAIN RESEARCH REVIEWS (2008)
Neurotrophic factors in Alzheimer's disease:: role of axonal transport
K. Schindowski et al.
GENES BRAIN AND BEHAVIOR (2008)
Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
M. Marcade et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Aspirin in Alzheimer's disease (AD2000): a randomised open-label trial
LANCET NEUROLOGY (2008)
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Paul H. Gordon et al.
LANCET NEUROLOGY (2007)
Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain
A. Nistor et al.
NEUROBIOLOGY OF AGING (2007)
Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease
Rashid Deane et al.
CURRENT ALZHEIMER RESEARCH (2007)
The role of tau phosphorylation and cleavage in neuronal cell death
Wanjoo Chun et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches
Bianca Van Broeck et al.
NEURODEGENERATIVE DISEASES (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Mitochondrial Aβ:: A potential cause of metabolic dysfunction in Alzheimer's disease
Xi Chen et al.
IUBMB LIFE (2006)
ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced α-secretase cleavage of amyloid precursor protein
Demian F. Obregon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Copper-mediated amyloid-β toxicity is associated with an intermolecular histidine bridge
David P. Smith et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Apolipoprotein E4: A causative factor and therapeutic target in neuropathology including Alzheimer's disease
RW Mahley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Amyloid β and neuromelanin -: Toxic or protective molecules?: The cellular context makes the difference
K. S. J. Rao et al.
PROGRESS IN NEUROBIOLOGY (2006)
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
A Familian et al.
GLIA (2006)
Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1
M Ohno et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides
P Marambaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice
K Rezai-Zadeh et al.
JOURNAL OF NEUROSCIENCE (2005)
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment
LJ Thal et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Alzheimer disease and Down syndrome: factors in pathogenesis
IT Lott et al.
NEUROBIOLOGY OF AGING (2005)
Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases
L Cartier et al.
BRAIN RESEARCH REVIEWS (2005)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Transgenic animal models of tauopathies
VMY Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Amyloid-β-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression
TB Liu et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Rofecoxib - No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study
SA Reines et al.
NEUROLOGY (2004)
BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease
M Ohno et al.
NEURON (2004)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
Atorvastatin-induced activation of Alzheimer's α secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding
S Parvathy et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Neurogenic effect of β-amyloid peptide in the development of neural stem cells
MA López-Toledano et al.
JOURNAL OF NEUROSCIENCE (2004)
Association between statin use and Alzheimer's disease
E Zamrini et al.
NEUROEPIDEMIOLOGY (2004)
Human Aβ1-42 reduces iron-induced toxicity in rat cerebral cortex
GM Bishop et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
PS Aisen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Adult mouse astrocytes degrade amyloid-β in vitro and in situ
T Wyss-Coray et al.
NATURE MEDICINE (2003)
Deposits of fibrillar Aβ do not cause neuronal loss or ferritin expression in adult rat brain
GM Bishop et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Caspase cleavage of the amyloid precursor protein modulates amyloid beta-protein toxicity
DC Lu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Microglia as neuroprotective, immunocompetent cells of the CNS
WJ Streit
GLIA (2002)
Minocycline slows disease progression in a mouse model of arnyotrophic lateral sclerosis
J Kriz et al.
NEUROBIOLOGY OF DISEASE (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
BACE knockout mice are healthy despite lacking the primary β-secretase activity in brain:: implications for Alzheimer's disease therapeutics
SL Roberds et al.
HUMAN MOLECULAR GENETICS (2001)
Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation
Y Luo et al.
NATURE NEUROSCIENCE (2001)
Redox-active iron mediates amyloid-β toxicity
CA Rottkamp et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice
T Ishihara et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
C Janus et al.
NATURE (2000)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Age-related amyloid β deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid β precursor protein Swedish mutant is not associated with global neuronal loss
A Takeuchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
A monoclonal antibody to amyloid precursor protein induces neuronal apoptosis
TT Rohn et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
A Probst et al.
ACTA NEUROPATHOLOGICA (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
A randomized controlled trial of prednisone in Alzheimer's disease
PS Aisen et al.
NEUROLOGY (2000)
Oxidative stress and Alzheimer disease
Y Christen
AMERICAN JOURNAL OF CLINICAL NUTRITION (2000)
PD98059 prevents neurite degeneration induced by fibrillar beta-amyloid in mature hippocampal neurons
M Rapoport et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
